Shots: Purdue to receive one-time payment from Eisai, while releasing itself from rights to develop & commercialize lemborexant. Eisai acquires WW development and commercialization rights for lemborexant, previously held by […]readmore
Tags : Purdue Pharma
Shots: Alivio to receive $14.75M upfront, $260M milestones, license exercise payments and royalties on sales of product from Purdue. Purdue to get an option to add more compounds to the […]readmore
Shots: Klaria to receive $55.2M as total deal value, including $5.2M as near-term milestones and royalties on sales from Purdue. Purdue to get exclusive license rights to develop & commercialize […]readmore